Cite
HARVARD Citation
Ehret, F. et al. (2023). Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH‐mutant and 1p/19q‐codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report. Neuropathology & applied neurobiology. 49 (1), p. n/a. [Online].